Literature DB >> 32109361

Indigenous Microbiota Protects against Inflammation-Induced Osteonecrosis.

D W Williams1,2, H E Vuong3, S Kim1,2, A Lenon1, K Ho1, E Y Hsiao3, E C Sung4, R H Kim1,2,5.   

Abstract

Medication-related osteonecrosis of the jaw (MRONJ) is a rare intraoral lesion that occurs in patients undergoing long-term and/or high-dose therapy with nitrogen-containing bisphosphonates, a RANKL inhibitor, antiangiogenic agents, or mTOR inhibitors. The presence of pathogenic bacteria is highly associated with advanced stages of MRONJ lesions; however, the exact role of indigenous microbes in MRONJ development is unknown. Here, we report that the normal oral flora in mice protects against inflammation-induced osteonecrosis. In mice that developed osteonecrosis following tooth extraction, there was increased bacterial infiltration when compared with healed controls. Antibiotic-mediated oral dysbiosis led to a local inhibition of bone resorption in the presence of ligature-induced periodontitis (LIP). There was no significant difference in empty lacunae, necrotic bone formation, osteoclast number, and surface area in antibiotic-treated as compared with conventionally colonized mice following extraction of healthy teeth after zoledronic acid infusions. However, extraction of LIP teeth led to increased empty lacunae, necrotic bone, and osteoclast surface area in antibiotic- and zoledronic acid-treated mice as compared with conventionally colonized mice. Our findings suggest that the presence of the indigenous microbiota protects against LIP-induced osteonecrosis.

Entities:  

Keywords:  antibiotic(s); bone; ligature-induced periodontitis/periodontal disease; medication-related osteonecrosis of the jaw/MRONJ; osteoclast(s); wound healing

Mesh:

Substances:

Year:  2020        PMID: 32109361      PMCID: PMC7243424          DOI: 10.1177/0022034520908594

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  40 in total

1.  Zoledronate Impairs Socket Healing after Extraction of Teeth with Experimental Periodontitis.

Authors:  A Soundia; D Hadaya; N Esfandi; I Gkouveris; R Christensen; S M Dry; O Bezouglaia; F Pirih; N Nikitakis; T Aghaloo; S Tetradis
Journal:  J Dent Res       Date:  2017-09-27       Impact factor: 6.116

2.  Open source software for semi-automated histomorphometry of bone resorption and formation parameters.

Authors:  Rob J van 't Hof; Lorraine Rose; Euphemie Bassonga; Anna Daroszewska
Journal:  Bone       Date:  2017-03-31       Impact factor: 4.398

3.  Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat.

Authors:  Tara L Aghaloo; Ben Kang; Eric C Sung; Michael Shoff; Matthew Ronconi; Jack E Gotcher; Olga Bezouglaia; Sarah M Dry; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

4.  Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk.

Authors:  Marcin Kos; Joachim F Kuebler; Klaudiusz Luczak; Werner Engelke
Journal:  J Craniomaxillofac Surg       Date:  2009-07-09       Impact factor: 2.078

5.  Optimization of the ligature-induced periodontitis model in mice.

Authors:  Toshiharu Abe; George Hajishengallis
Journal:  J Immunol Methods       Date:  2013-05-12       Impact factor: 2.303

6.  Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice.

Authors:  Drake W Williams; Cindy Lee; Terresa Kim; Hideo Yagita; Hongkun Wu; Sil Park; Paul Yang; Honghu Liu; Songtao Shi; Ki-Hyuk Shin; Mo K Kang; No-Hee Park; Reuben H Kim
Journal:  Am J Pathol       Date:  2014-08-28       Impact factor: 4.307

7.  The Mouse Intestinal Bacterial Collection (miBC) provides host-specific insight into cultured diversity and functional potential of the gut microbiota.

Authors:  Ilias Lagkouvardos; Rüdiger Pukall; Birte Abt; Bärbel U Foesel; Jan P Meier-Kolthoff; Neeraj Kumar; Anne Bresciani; Inés Martínez; Sarah Just; Caroline Ziegler; Sandrine Brugiroux; Debora Garzetti; Mareike Wenning; Thi P N Bui; Jun Wang; Floor Hugenholtz; Caroline M Plugge; Daniel A Peterson; Mathias W Hornef; John F Baines; Hauke Smidt; Jens Walter; Karsten Kristiansen; Henrik B Nielsen; Dirk Haller; Jörg Overmann; Bärbel Stecher; Thomas Clavel
Journal:  Nat Microbiol       Date:  2016-08-08       Impact factor: 17.745

8.  Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.

Authors:  Robert E Marx
Journal:  J Oral Maxillofac Surg       Date:  2003-09       Impact factor: 1.895

9.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; John Fantasia; Reginald Goodday; Tara Aghaloo; Bhoomi Mehrotra; Felice O'Ryan
Journal:  J Oral Maxillofac Surg       Date:  2014-05-05       Impact factor: 2.136

10.  Antibiotic treatment at delivery shapes the initial oral microbiome in neonates.

Authors:  Luisa F Gomez-Arango; Helen L Barrett; H David McIntyre; Leonie K Callaway; Mark Morrison; Marloes Dekker Nitert
Journal:  Sci Rep       Date:  2017-02-27       Impact factor: 4.379

View more
  7 in total

1.  Long-Term Ligature-Induced Periodontitis Exacerbates Development of Bisphosphonate-Related Osteonecrosis of the Jaw in Mice.

Authors:  Drake Winslow Williams; Katie Ho; Allison Lenon; Sol Kim; Terresa Kim; Yousang Gwack; Reuben H Kim
Journal:  J Bone Miner Res       Date:  2022-06-09       Impact factor: 6.390

2.  Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.

Authors:  Timothy J Break; Vasileios Oikonomou; Nicolas Dutzan; Jigar V Desai; Marc Swidergall; Tilo Freiwald; Daniel Chauss; Oliver J Harrison; Julie Alejo; Drake W Williams; Stefania Pittaluga; Chyi-Chia R Lee; Nicolas Bouladoux; Muthulekha Swamydas; Kevin W Hoffman; Teresa Greenwell-Wild; Vincent M Bruno; Lindsey B Rosen; Wint Lwin; Andy Renteria; Sergio M Pontejo; John P Shannon; Ian A Myles; Peter Olbrich; Elise M N Ferré; Monica Schmitt; Daniel Martin; Daniel L Barber; Norma V Solis; Luigi D Notarangelo; David V Serreze; Mitsuru Matsumoto; Heather D Hickman; Philip M Murphy; Mark S Anderson; Jean K Lim; Steven M Holland; Scott G Filler; Behdad Afzali; Yasmine Belkaid; Niki M Moutsopoulos; Michail S Lionakis
Journal:  Science       Date:  2021-01-15       Impact factor: 47.728

Review 3.  Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  J I Aguirre; E J Castillo; D B Kimmel
Journal:  Bone       Date:  2021-09-11       Impact factor: 4.398

Review 4.  The Role of the Immune Response in the Development of Medication-Related Osteonecrosis of the Jaw.

Authors:  Weidong Zhang; Ling Gao; Wenhao Ren; Shaoming Li; Jingjing Zheng; Shasha Li; Chunmiao Jiang; Shuying Yang; Keqian Zhi
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 5.  Interactions of the microbiome with pharmacological and non-pharmacological approaches for the management of ageing-related musculoskeletal diseases.

Authors:  Maria Papageorgiou; Emmanuel Biver
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-04-20       Impact factor: 5.346

6.  Indigenous microbiota protects development of medication-related osteonecrosis induced by periapical disease in mice.

Authors:  Wen Du; Mengyu Yang; Terresa Kim; Sol Kim; Drake W Williams; Maryam Esmaeili; Christine Hong; Ki-Hyuk Shin; Mo K Kang; No-Hee Park; Reuben H Kim
Journal:  Int J Oral Sci       Date:  2022-03-21       Impact factor: 6.344

Review 7.  Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  Ran Yan; Ruixue Jiang; Longwei Hu; Yuwei Deng; Jin Wen; Xinquan Jiang
Journal:  Int J Oral Sci       Date:  2022-08-10       Impact factor: 24.897

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.